iRhythm Technologies, Inc.

IRTC

US4500561067

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2024-07-08 pm EDT			5-day change	1st Jan Change
95.9 ^USD	-3.63%		-9.91%	-10.41%

Jun. 20	IRhythm Technologies Shares Rise After Upgrade From Wolfe Research	MT
Jun. 20	Wolfe Research Upgrades iRhythm Technologies to Outperform From Peer Perform, Price Target is $115	MT

IRhythm Technologies, Inc. Provides Revenue Guidance for the Full Year 2022

February 23, 2022 at 04:13 pm EST

iRhythm Technologies, Inc. projects revenue for the full year 2022 to range from $400 million to $410 million, which represents 24% to 27% growth over prior year results.

Latest news about iRhythm Technologies, Inc.

IRhythm Technologies Shares Rise After Upgrade From Wolfe Research	Jun. 20	MT
Wolfe Research Upgrades iRhythm Technologies to Outperform From Peer Perform, Price Target is $115	Jun. 20	MT
IRhythm Technologies, Inc. Achieves Significant Operational Milestone with Launch of Initial Phase of Manufacturing Automation	Jun. 17	CI
Transcript : IRhythm Technologies, Inc. Presents at The 44th Annual William Blair Growth Stock Conference, Jun-05-2024 11:20 AM	Jun. 05
Needham Adjusts iRhythm Technologies' PT to $138 From $137, Says 'Strong' Q1 Revenue Growth Should Continue; Keeps Buy Rating	May. 03	MT
Transcript : IRhythm Technologies, Inc., Q1 2024 Earnings Call, May 02, 2024	May. 02
Earnings Flash (IRTC) IRHYTHM Posts Q1 Revenue $131.9M, vs. Street Est of $128.4M	May. 02	MT
IRhythm Technologies, Inc. Revises Earnings Guidance for the Year 2024	May. 02	CI
IRhythm Technologies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 02	CI
IRhythm Technologies Closes $661 Million Notes Offering	Mar. 08	MT
Irhythm Technologies Insider Sold Shares Worth $360,983, According to a Recent SEC Filing	Mar. 05	MT
IRhythm Technologies Prices $575 Million Convertible Notes Offering	Mar. 05	MT
IRhythm Shares Fall After Firm Plans $450 Million Convertible Notes Offering	Mar. 04	MT
IRhythm Technologies Plans to Offer $450 in Convertible Notes Due 2029	Mar. 04	MT
Needham Adjusts iRhythm Technologies' Price Target to $137 From $136, Keeps Buy Rating	Feb. 23	MT
IRhythm Technologies Q4 Adjusted Loss Widens, Revenue Rises; 2024 Sales Outlook Set -- Shares Slump After Hours	Feb. 22	MT
Transcript : IRhythm Technologies, Inc., Q4 2023 Earnings Call, Feb 22, 2024	Feb. 22
IRhythm Technologies, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 22	CI
IRhythm Technologies, Inc. Provides Earnings Guidance for the Year 2024	Feb. 22	CI
IRhythm Technologies, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 22	CI
Transcript : IRhythm Technologies, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 04:30 PM	Jan. 08
IRhythm Technologies Closes $150 Million Debt Facility; 2024 Revenue Forecast Issued	Jan. 08	MT
Needham Raises iRhythm Technologies' Price Target to $136 From $108, Keeps Buy Rating	Jan. 08	MT
Irhythm Technologies, Inc. Entered into A Credit, Security and Guaranty Agreement with Braidwell Transaction Holdings LLC	Jan. 08	CI
IRhythm Technologies, Inc. Revises Revenue Guidance for the Year 2024	Jan. 08	CI

Chart iRhythm Technologies, Inc.

Duration

Period

More charts

iRhythm Technologies, Inc. is a digital health care company, which creates solutions that detect, predict, and prevent disease. The Company designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. It offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. It offers its Zio ambulatory cardiac monitoring services, including long-term continuous monitoring, short-term continuous monitoring, and mobile cardiac telemetry monitoring services (Zio Services), using its Zio Systems. The Zio Monitor System is a prescription-only, remote ECG monitoring system that consists of a patch ECG monitor (the Zio Monitor patch) that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software (ZEUS) System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-07-31 - Q2 2024 Earnings Release (Projected)

Related indices

Russell 2000

More about the company